Therapies for Stroke Prevention in Atrial Fibrillation
Therapies for Stroke Prevention in Atrial Fibrillation is organized by Nurse.com - OnCourse Learning Corporation.
Description:
Atrial fibrillation (AFib) is the most common abnormal heart rhythm and affects 2.7 to 6.1 million people in the U.S. and studies suggest that the incidence and prevalence is increasing (CDC, 2020). AFib is associated with a fivefold increase in the risk of ischemic stroke. In fact, 1 in 7 strokes are caused by AFib (CDC, 2020). Several guidelines recommend patients with AFib NOT identified as “low risk” for stroke be offered anticoagulation therapy. However, these medications are associated with an increased risk for bleeding. Thus, several factors must be considered when determining the most appropriate therapy and modifiable risk factors should be treated before initiating treatment.
Goal and Learning Outcomes:
The goal of this course is to educate nursing professionals, pharmacists, and providers on therapies for stroke prevention in atrial fibrillation.
After taking this course, you should be able to:
• Describe the general pathophysiology, classifications, symptoms, and risk factors for atrial fibrillation and the connection between atrial fibrillation and stroke.
• Compare pharmacological and nonpharmacological therapies approved for use in atrial fibrillation to reduce the risk of stroke.
• Recognize areas of practice where nurses, providers, and pharmacists can work together to optimize the use of therapies for preventing stroke in patients with atrial fibrillation.